Daily News Podcast

No meaningful decline in opioid use


 

Over the last decade, opioid use has not significantly declined, despite efforts to educate physicians about the risk of abuse. Also today, the Fitbit Flex is feasible and provides nuanced step-count data in patients with MS, even moderate alcohol use could worsen outcomes in nonalcoholic fatty liver disease, and a new study supports meningococcal B vaccine in children with rare diseases. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Is fibromyalgia one disorder – or two?
MDedge Hematology and Oncology
Is fish oil’s heart benefit a fish tale?
MDedge Hematology and Oncology
Blood pressure meds cut cognitive impairment risk
MDedge Hematology and Oncology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Hematology and Oncology
CTCs linked to late recurrence in HER2–, HR+ breast cancer
MDedge Hematology and Oncology
Free skin cancer screening highlights need
MDedge Hematology and Oncology
Valsartan cancer risk is low
MDedge Hematology and Oncology
Finally, new migraine drugs
MDedge Hematology and Oncology
Changes to doctor payment for in-office drugs
MDedge Hematology and Oncology
E-cigarettes: Prices down, sales up
MDedge Hematology and Oncology